InsiderTrades

Form 4 for MRSH Marsh McLennan

Accepted 2024-08-26 00:00:00 ET · period of report 2024-08-22 · accession 0001127602-24-022910 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-08-26 2024-08-22 MRSH MCGIVNEY MARK C CFO M - OptEx $118.87 +50.9K 84.6K +151% +$6.05M
D 2024-08-26 2024-08-22 MRSH MCGIVNEY MARK C CFO S - Sale+OE $225.22 -50.9K 33.7K -60% -$11.47M
D 2024-08-26 2024-08-22 MRSH MCGIVNEY MARK C CFO M - OptEx $0.00 -50.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-08-22 M A 50,928 $118.87 84,606 D — —
2 Common Common Stock 2024-08-22 S D 50,928 $225.22 33,678 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225 to $225.580. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
3 Derivative Stock Options (Right to Buy) 2024-08-22 M D 50,928 $0.00 0 D $118.87 · — to 2030-02-18 50,928 Common Stock (F3) These options were granted on February 19, 2020 and vested in four equal annual installments on February 19th of 2021, 2022, 2023 and 2024.